All stock lists
Atrium Therapeutics, Inc. (NASDAQ:RNA)
US · Delayed Price · Currency is USD
8.20+0.04 (+0.49%)
Insider Score
––Not scored
RNA Insider Score
Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
RNA analyst forecast
RNA analyst consensus
No analyst ratings in the last 3 months.
RNA 12-month price target
$15.00+85.3% upsideaverage of 1 firm
$15.00High
$15.00Low
Best analysts covering RNA
No firm covering RNA has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
RNA analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| Roth Capital | — | $15.00 | +87.5% | — | 2026-10-22 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.